Correction
To further confirm that the inactivation of Lyn inhibited CD24-induced ERK1/2 activation, we submitted the results of another CD24siRNA (CD24siRNA-2) as the Additional file 1: Figure S2. After publication of the article [1] the authors noted that the wrong figure for Additional file 1: Figure S2 was submitted by mistake. The correct image was conducted in SW480CD24 using CD24siRNA-2 (new Additional file 1: attached). The authors apologise for any inconvenience caused.
Supplementary Material
Figure S1: Densitometry results of Figure 1A; Figure S2: CD24siRNA-2 results; Figure S3: Means ± standard errors (SE) for three independent experiments for Figure 4.
Contributor Information
Ning Su, Email: ningsu126@126.com.
Liang Peng, Email: wspengliang@sina.com.
Bingqing Xia, Email: hidy12388@126.com.
Yingying Zhao, Email: yingying850130@gmail.com.
Angao Xu, Email: mrangao@gmail.com.
Jing Wang, Email: wangjing582@163.com.
Xinying Wang, Email: helen2003517@163.com.
Bo Jiang, Email: drjiang@163.com.
References
- Su N, Peng L, Xia B, Zhao Y, Xu A, Wang J, Wang X, Jiang B. Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer. Mol Cancer. 2012;11:43. doi: 10.1186/1476-4598-11-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Figure S1: Densitometry results of Figure 1A; Figure S2: CD24siRNA-2 results; Figure S3: Means ± standard errors (SE) for three independent experiments for Figure 4.